Pharmaceutical involvement in phase II breast cancer clinical trials

被引：1
|
作者：
Schneider, A.
Zhang, T.
Kamal, A.
Patel, K.
Hamilton, E. P.
Peppercorn, J. M.
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6104
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The group sequential triangular test for phase II cancer clinical trials
    Bellissant, E
    Benichou, J
    Chastang, C
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (04): : 422 - 430
  • [32] Phase II cancer clinical trials for biomarker-guided treatments
    Jung, Sin-Ho
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (02) : 256 - 263
  • [33] Randomized Phase II Cancer Clinical Trials to Validate Predictive Biomarkers
    Zhang, Baoshan
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Jung, Sin-Ho
    BIOMEDICINES, 2024, 12 (10)
  • [34] Photosensitizer Radachlorin®: Skin cancer PDT phase II clinical trials
    Kochneva, Elena V.
    Filonenko, Elena V.
    Vakulovskaya, Elena G.
    Scherbakova, Elena G.
    Seliverstov, Oleg V.
    Markichev, Nikolay A.
    Reshetnickov, Andrei V.
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2010, 7 (04) : 258 - 267
  • [35] Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials
    Criscitiello, Carmen
    Marra, Antonio
    Morganti, Stefania
    Zagami, Paola
    Gandini, Sara
    Esposito, Angela
    Curigliano, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 40 - 49
  • [36] RANDOMIZED PHASE II CLINICAL TRIALS
    Jung, Sin-Ho
    Sargent, Daniel J.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (04) : 802 - 816
  • [37] Current phase II and phase III clinical trials for pancreatic cancer - Referral resource
    Mooney, MM
    Schoenfeldt, M
    ONCOLOGY-NEW YORK, 2004, 18 (08): : 1008 - +
  • [38] Nursing, morality, and emotions: Phase I and phase II clinical trials and patients with cancer
    Krishnasamy, M
    CANCER NURSING, 1999, 22 (04) : 251 - 259
  • [39] PHASE-II TRIALS WITH TOREMIFENE IN ADVANCED BREAST-CANCER - A REVIEW
    VALAVAARA, R
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 16 : S31 - S35
  • [40] ELIGIBILITY OF EPIGALLOCATECHIN GALLATE (EGCG) FOR PHASE II BREAST CANCER CHEMOPREVENTION TRIALS
    Iatropoulos, G. F.
    ANNALS OF ONCOLOGY, 2009, 20 : 61 - 62
12345